Zydus and Torrent Collaborate to Market Diabetes and Weight-Loss Injection in India

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Zydus, Torrent Partner to Launch Diabetes & Weight-Loss Injection in India

Zydus, Torrent Partner to Launch Diabetes & Weight-Loss Injection in India

C

CNBC TV18•18-03-2026, 16:32

Zydus, Torrent Partner to Launch Diabetes & Weight-Loss Injection in India

•Zydus Lifesciences and Torrent Pharmaceuticals will co-market Semaglutide Injection in India.
•Zydus will manufacture and supply the product, while Torrent Pharma will market it under the brand Sembolic.
•Zydus will also market the product under its brands Semaglyn, Mashema, and Alterme.
•The innovative formulation comes in a prefilled cartridge with a reusable pen device for patient convenience.
•Semaglutide is indicated for type 2 diabetes and chronic weight management in adults.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

Representational image (Image: News18)

Zydus, Torrent Pharma Partner to Co-Market Semaglutide Injection for Diabetes, Weight Management

Lupin, Zydus Partner to Co-Market Semaglutide Injection in India

Lupin, Zydus Partner to Co-Market Semaglutide Injection in India

Representational image (Image: News18)

Zydus, Lupin Partner to Co-Market Diabetes Drug Semaglutide in India

Semaglutide

Semaglutide Patent Expires: Generics Flood Market, Prices Plummet 50-70%

Representational image (Image: News18)

Eris Lifesciences, Natco Pharma Partner to Commercialize Semaglutide in India

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. File pic/Reuters

Ozempic Patent Expires: Indian Pharma Unleashes 'Sema' Storm with 50+ Generic Brands, Prices to Halve